Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40K3N | ISIN: US8677817004 | Ticker-Symbol:
NASDAQ
06.06.25 | 22:00
1,510 US-Dollar
+2,03 % +0,030
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SUNSHINE BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
SUNSHINE BIOPHARMA INC 5-Tage-Chart

Aktuelle News zur SUNSHINE BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SUNSHINE BIOPHARMA Aktie jetzt für 0€ handeln
19.05.Sunshine Biopharma Inc. - 8-K, Current Report3
16.05.Sunshine Biopharma reports Q1 results5
15.05.Sunshine Biopharma Inc.: Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year369FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...
► Artikel lesen
06.05.Sunshine Biopharma launches generic antipsychotic drug3
06.05.Sunshine Biopharma Inc.: Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market250FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...
► Artikel lesen
21.04.Sunshine Biopharma steigt mit Everolimus in den kanadischen Generikamarkt ein2
21.04.Sunshine Biopharma Inc.: Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion247FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
► Artikel lesen
03.04.Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering291FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...
► Artikel lesen
02.04.Sunshine Biopharma sichert sich 2,46 Millionen US-Dollar durch Aktienangebot4
02.04.Sunshine Biopharma secures $2.46 million in stock offering4
02.04.Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules288FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...
► Artikel lesen
02.04.Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug2
02.04.Sunshine Biopharma Inc. - 8-K, Current Report3
02.04.Sunshine Biopharma reports progress in liver cancer treatment3
02.04.Sunshine Biopharma Inc.: Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer210FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in...
► Artikel lesen
02.04.Sunshine Biopharma reports FY results2
01.04.Sunshine Biopharma Inc.: Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year383FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...
► Artikel lesen
01.04.Sunshine Biopharma Inc. - 10-K, Annual Report2
31.03.Sunshine Biopharma Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4052
24.03.Sunshine Biopharma bringt neue Antibiotika in Kanada auf den Markt6
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1